FINAL DEADLINE: Ovarian Cancer Victims Have Until 5pm ET Today to Vote on Approximately $8 Billion J&J Talc Compensation Plan
26 July 2024 - 11:05PM
Business Wire
Those Who Previously Voted “No” Can Still
Switch Their Vote to “Yes”
Today at 5pm ET is the final
deadline for tens of thousands of ovarian cancer victims or their
representatives to vote on the approximately $8 billion Johnson
& Johnson (“J&J”) (NYSE: JNJ) talcum powder settlement,
leaving claimants just hours to
act.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240726806059/en/
Haven't voted in favor of the talcum
powder plan yet? There's still time. (Graphic: Business Wire)
Talc claimants can vote on the plan at
www.OfficialTalcClaims.com or by calling 1-888-431-4056.
The approximately $8 billion plan, which has a net present value
of $6.475 billion, will compensate current and future claimants who
were harmed by J&J’s talcum powder products, putting an end to
a lengthy, frustrating litigation process. Under the plan, ovarian
cancer claimants are expected to receive an average of $75,000 to
$150,000 each.
In order for claimants and families to achieve the timely and
fair compensation they deserve, at least 75% of the people
casting votes must vote YES on the plan.
The Ad Hoc Group of Counsel – representing more than 77,500
individuals in this matter – urges all individuals harmed by
J&J baby powder products and their attorneys to take action
now before the deadline of 5pm ET
today.
If you have already voted “no” and are
having second thoughts, it’s not too late: Only your latest vote
counts and will override any prior vote you cast. Please know that
your voting decision is completely confidential.
The Ad Hoc Group of Counsel believes that law firms opposing the
settlement have attempted to sway voters towards continued
litigation, because doing so would result in hundreds of millions
of dollars in fees to the lawyers. Those extra payments to
attorneys would not be available through a bankruptcy
settlement.
At this critical time, the Ad Hoc Group of Counsel is providing
detailed responses to the misleading claims put forth by opposing
law firms so that all J&J claimants can make an informed voting
decision.
- What They Claim: There is no way of knowing how much
claimants will be paid or when. The Truth: Under the J&J
bankruptcy plan, ovarian cancer claimants are projected to receive
an average recovery of between $75,000 and $150,000.
- What They Claim: Claimants are being deprived of the
right to choose to settle. The Truth: By voting on J&J’s
bankruptcy plan, people are actually making their voice heard and
preserving their ability to participate in this historic settlement
of approximately $8 billion through a process that eliminates
litigation risk.
- What They Claim: Claimants have a better chance of
succeeding if they vote “no” and take their case to trial. The
Truth: In over a decade of litigation, just 17 ovarian cancer
cases have gone to trial. J&J and its subsidiaries have
prevailed in 16 of those cases, with plaintiffs recovering no
money.
- What They Claim: Resolution through multidistrict litigation
(MDL) is the fairest way to handle these cases. The Truth:
The law firms opposing the settlement have had ample time to reach
a resolution through MDL, but their efforts to reach a consensus
have not been successful.
- What They Claim: There are thousands of “fantasy cases” among
those voting to support the plan. The Truth: Our clients are
real people who have suffered greatly
as a result of using J&J talc products. This statement is
deeply offensive to the tens of thousands of talc victims
represented by the Ad Hoc Group of Counsel.
- What They Claim: People diagnosed with ovarian cancer in the
future due to their past use of talc products won't be able to hold
J&J accountable. The Truth: A future claims
representative is representing the rights of future claimants, and
those future victims will have the same recovery rights as current
claimants.
- What They Claim: Voting against the plan will make J&J
suffer. The Truth: Voting “no” hurts victims, not J&J.
If the proposed plan fails to garner enough “yes” votes, these
victims will not receive compensation for their suffering for
years, if ever.
- What They Claim: If J&J is able to resolve this matter
through bankruptcy, other corporations will also seek to escape
mass tort liability and jury trials through the bankruptcy process.
The Truth: If this vote succeeds, J&J will be paying an
historic amount - approximately $8 billion - to settle claims. The
company is being held accountable for the harm its products
caused.
Ovarian cancer survivor Tamika Evans, 47, of Chicago voted to
approve the plan. She stated: “I support this settlement because I
need help with my ongoing treatment costs and to recover from the
medical debt. It’s about more than money – it’s about acknowledging
the impact on our lives.”
As Anna Maria Sanderford, 61, of Arizona, stated: “We need to
get this settlement done so we can go on with our lives and do what
we want with the time we have left.”
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240726806059/en/
Docket Communications talc@docketcommunications.com
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Sep 2023 to Sep 2024